A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects
A Two-week, Randomised, Double-blind Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects (≥ 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT® pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Act. Twice Daily
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
Alabama
-
Muscle Shoals, Alabama, Forenede Stater
- Research Site
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater
- Research Site
-
-
California
-
Anaheim, California, Forenede Stater
- Research Site
-
Los Angeles, California, Forenede Stater
- Research Site
-
Palmdale, California, Forenede Stater
- Research Site
-
Rolling Hills Estates, California, Forenede Stater
- Research Site
-
-
Colorado
-
Denver, Colorado, Forenede Stater
- Research Site
-
Wheat Ridge, Colorado, Forenede Stater
- Research Site
-
-
Connecticut
-
Stamford, Connecticut, Forenede Stater
- Research Site
-
-
Delaware
-
Wilmington, Delaware, Forenede Stater
- Research Site
-
-
Florida
-
Miami, Florida, Forenede Stater
- Research Site
-
-
Indiana
-
Avon, Indiana, Forenede Stater
- Research Site
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater
- Research Site
-
-
Kansas
-
Shawnee Mission, Kansas, Forenede Stater
- Research Site
-
-
Louisiana
-
Mandeville, Louisiana, Forenede Stater
- Research Site
-
-
Maryland
-
Wheaton, Maryland, Forenede Stater
- Research Site
-
-
Michigan
-
Bay City, Michigan, Forenede Stater
- Research Site
-
-
Missouri
-
Chesterfield, Missouri, Forenede Stater
- Research Site
-
Kansas City, Missouri, Forenede Stater
- Research Site
-
-
Nebraska
-
McCook, Nebraska, Forenede Stater
- Research Site
-
Scottsbluff, Nebraska, Forenede Stater
- Research Site
-
-
New Jersey
-
Brick, New Jersey, Forenede Stater
- Research Site
-
Princeton, New Jersey, Forenede Stater
- Research Site
-
-
New York
-
North Syracuse, New York, Forenede Stater
- Research Site
-
-
North Dakota
-
Bismarck, North Dakota, Forenede Stater
- Research Site
-
Fargo, North Dakota, Forenede Stater
- Research Site
-
-
Ohio
-
Akron, Ohio, Forenede Stater
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater
- Research Site
-
-
Oregon
-
Bend, Oregon, Forenede Stater
- Research Site
-
Lake Oswego, Oregon, Forenede Stater
- Research Site
-
-
Pennsylvania
-
Bensalem, Pennsylvania, Forenede Stater
- Research Site
-
Feasterville, Pennsylvania, Forenede Stater
- Research Site
-
Pittsburgh, Pennsylvania, Forenede Stater
- Research Site
-
-
Rhode Island
-
East Providence, Rhode Island, Forenede Stater
- Research Site
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater
- Research Site
-
Gaffney, South Carolina, Forenede Stater
- Research Site
-
Greer, South Carolina, Forenede Stater
- Research Site
-
-
South Dakota
-
Rapid City, South Dakota, Forenede Stater
- Research Site
-
Watertown, South Dakota, Forenede Stater
- Research Site
-
-
Texas
-
Boerne, Texas, Forenede Stater
- Research Site
-
Dallas, Texas, Forenede Stater
- Research Site
-
El Paso, Texas, Forenede Stater
- Research Site
-
San Antonio, Texas, Forenede Stater
- Research Site
-
Waco, Texas, Forenede Stater
- Research Site
-
-
Utah
-
Provo, Utah, Forenede Stater
- Research Site
-
-
Washington
-
Spokane, Washington, Forenede Stater
- Research Site
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Male or Female, > 18 years of age
- Mild to moderate asthma requiring treatment with an inhaled corticosteroid
- Diagnosis of asthma for at least 6 months
Exclusion Criteria:
- Subjects requiring treatment with systemic corticosteroids (e.g., oral, parenteral, ocular)
- Subjects with severe asthma, as judged by investigator
- Any significant disease or disorder that may jeopardize a subject's safety
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
|---|
|
To determine whether subjects respond similarly to the Onset of Effect Questionnaire items 2 and 5 when administered post-dose versus pre-dose and does that difference favour a bronchodilator treatment group over a non-bronchodilator treatment group
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
|---|
|
To determine if there is an association between the immediate physiological response to medication and the responses to OEQ items 2 and 5 and to determine what subjects mean when they say they feel their asthma maintenance medication 'working right away
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Tomas LG Andersson, MD, AstraZenenca
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Luftvejssygdomme
- Sygdomme i immunsystemet
- Lungesygdomme
- Overfølsomhed, Øjeblikkelig
- Bronchiale sygdomme
- Lungesygdomme, obstruktiv
- Respiratorisk overfølsomhed
- Overfølsomhed
- Astma
- Lægemidlers fysiologiske virkninger
- Adrenerge midler
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Autonome agenter
- Agenter fra det perifere nervesystem
- Anti-inflammatoriske midler
- Glukokortikoider
- Hormoner
- Hormoner, hormonsubstitutter og hormonantagonister
- Adrenerge agonister
- Bronkodilatatorer
- Anti-astmatiske midler
- Respiratoriske midler
- Adrenerge beta-2-receptoragonister
- Adrenerge beta-agonister
- Budesonid
- Formoterolfumarat
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- D5896C00025
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .